RT Journal Article
SR Electronic
T1 Control Strategies to Curtail Transmission of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.04.20053173
DO 10.1101/2020.04.04.20053173
A1 Shah, Nita H.
A1 Suthar, Ankush H.
A1 Jayswal, Ekta N.
YR 2020
UL http://medrxiv.org/content/early/2020/04/07/2020.04.04.20053173.abstract
AB Recently the World Health Organization has declared the outbreak of a severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) as a pandemic, and declared it as Public Health Emergency of International Concern. More than 683,536 positive cases and 32,139 deaths caused by novel corona virus 2019 (COVID-19) has affected 199 countries and territories. This pandemic can transform into an extremely destructive form if we still do not take it seriously. In the present study, we propose a generalized SEIR model of COVID-19 to study the behaviour of its transmission under different control strategies. In the model, all possible cases of human to human transmission are taken care and its reproduction number is formulated to analyse accurate transmission dynamics of the coronavirus outbreak. Optimal control theory is applied in the model to pretend the impact of various intervention strategies, including voluntary quarantine, isolation of infected individuals, improving an individual’s immunity and hospitalisation. Also, effect of the control strategies on model is analysed graphically by simulating the model numerically.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSecond author (AHS) is funded by a Junior Research Fellowship from the Council of Scientific & Industrial Research (file no.-09/070(0061)/2019-EMR-I) and all the authors are thankful to DST-FIST file # MSI-097 for technical support to the Department of Mathematics, Gujarat University. Third author (ENJ) is funded by UGC granted National Fellowship for Other Backward Classes (NFO-2018-19-OBC-GUJ-71790).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is included within the manuscript.